Propofol

When ATH:
N01AX10

Pharmacological action.
Anesthesia, sedation.

Application.

Induction and maintenance of general anesthesia, sedation during mechanical ventilation.

Contraindications.

Hypersensitivity.

Restrictions to the use of.

Natural infancy (to 3 years), lactation.

Side effects.

Short-term cessation of breathing, breathlessness; rarely convulsions, opisthotonus, pulmonary edema; в период пробуждения — головная боль, nausea, vomiting, postoperative fever (rarely).

Cooperation.

Compatible with preparations for spinal and epidural anesthesia, medicine, used in premedication, with muscle relaxants and analgesics.

Overdose.

Manifested oppression of cardiac activity and respiration. Treatment is symptomatic for background ventilation (oxygen), maintaining hemodynamic (IV fluids and vasopressors).

Dosing and Administration.

B /. Для вводной анестезии взрослым вводят по 40 mg every 10 from (before clinical signs of anesthesia), older children 8 years - 2,5 mg / kg. For maintenance of anesthesia using continuous infusion or, or repeated bolus. Dose picked individually, адекватная анестезия достигается при введении со скоростью 4–12 мг/кг/ч, детям — 9–15 мг/кг/ч. To provide sedation in intensive care patients, on mechanical ventilation, в/в инфузируют со скоростью 0,3–4 мг/кг/ч.

Precautions.

In cases, when there is a possibility of side effects, associated with the activation of the vagus nerve, it is advisable before induction of anesthesia in / in a cholinolytic. Do not use in obstetric practice, tk. Propofol crosses the placenta and can cause neonatal depression (may use in the I trimester during operations abortion).

The risk of pain along the vein may be significantly reduced during infusion through a large vein diameter or simultaneous introduction of lidocaine. The injection can be done only by trained personnel with the possibility of immediate use of mechanical ventilation, -therapy, resuscitation in full.

Cooperation

Active substanceDescription of interaction
AzelastinFMR: synergism. Do effect; in postanesthesia period more significantly reduced the rate of psychomotor reactions.
AlprazolamFMR: synergism. Enhances anesthetic and sedation (mutually) effects; the combined appointment of possible distinct reduction in systolic, diastolic and mean arterial pressure and cardiac output.
BuprenorphineFMR: synergism. Strengthens (mutually) anesthetic and sedation; combined use may cause a decrease in cardiac output and blood pressure.
VancomycinFMR. Against the background of propofol increases the likelihood of erythema, histamine tides and anaphylactic shock.
HaloperidolFMR: synergism. Strengthens (mutually) CNS depression.
HalothaneFMR: synergism. Strengthens (mutually) effects. Against the background of increased risk of propofol kardiodepressii.
DiazepamFMR: synergism. Enhances anesthetic and sedation (mutually) effects; the combined appointment of possible distinct reduction in systolic, diastolic and mean arterial pressure and cardiac output.
DiltiazemFMR: synergism. Increases related to anesthesia, depression of cardiac contractility, conduction, automatism and vasodilatation.
DroperidolFMR: synergism. Strengthens (mutually) anesthetic and sedation. Against the background of propofol increased likelihood of decreased cardiac output and blood pressure.
ZolpidemFMR: synergism. Strengthens (mutually) effect.
IzofluranFMR: synergism. Strengthens (mutually) effect.
ClonazepamFMR: synergism. Strengthens (mutually) effects.
CodeineFMR: synergism. Strengthens (mutually) anesthetic and sedation; combined use may cause a decrease in cardiac output and blood pressure.
LorazepamFMR: synergism. Strengthens (mutually) effects.
MetoclopramideFMR. Do effect. Against the background of propofol attenuated stimulation of motor activity of the digestive tract.
MidazolamFMR: synergism. Strengthens (mutually) effect; the combined use of increased likelihood of decreased cardiac output and blood pressure.
Morphine sulfateFMR: synergism. Strengthens (mutually) anesthetic and sedation; combined use may cause a decrease in cardiac output and blood pressure.
OxazepamFMR: synergism. Strengthens (mutually) effects; the combined appointment of possible distinct reduction in systolic, diastolic and mean arterial pressure and cardiac output.
OxybutyninFMR: synergism. Against the background of propofol (postanesthesia period) increasing hypnotic effect.
PramipexoleFMR: synergism. Strengthens (mutually) sedation; In sharing caution: increasing the risk of side effects from the CNS.
TopiramateFMR: synergism. Do effect.
PhenobarbitalFMR: synergism. Enhances anesthetic and sedation (mutually) effects; the combined appointment increases the likelihood of reduction in cardiac output and blood pressure.
FentanylFMR: synergism. Increases (mutually) anesthetic and sedation; combined use can cause severe bradycardia, decreased cardiac output and blood pressure.
XlordiazepoksidFMR: synergism. Strengthens (mutually) effects.

Back to top button